Targeting rare human PCSK9 variants for cholesterol treatment
US8883157B1 · kind B1 · utility
34Cited by
30References
30Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 23, 2013 |
| Grant date | Nov 11, 2014 |
| Priority date | — |
| Expiry date | Dec 23, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to human targets of interest (TOI), anti-TOI ligands, kits compositions and method.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.